Context
Fetal zone steroids (FZS) are excreted in high concentrations in preterm infants. Experimental data suggest protective effects of FZS in models of neonatal disease.
Objective
We aimed to characterize the postnatal FZS metabolome of well preterm and term infants.
Methods
24-hour urinary FZS excretion rates were determined in early preterm (< 30 weeks gestational age), preterm (30-36 weeks) and term (>37 weeks) infants. Pregnenolone and 17-OH-pregnenolone metabolites (n=5), and DHEA and metabolites (n=12) were measured by gas chromatography-mass spectrometry (GC–MS). Postnatal concentrations of FZS were compared with already published prenatal concentrations in amniotic fluid.
Results
Excretion rates of total FZS and most of the single metabolites were highest in early preterm infants. In this group, excretion rates approach those of term infants at term equivalent postmenstrual age. Preterm infants of 30-36 weeks had more than half lower median excretion rates of FZS compared to early preterm infants at the same time of postmenstrual age. Postnatal concentrations of FZS were partly more than hundredfold higher in all gestational age groups compared to prenatal concentrations in amniotic fluid at mid gestation.
Conclusions
The excretion rates of FZS as a proxy of the involution of the fetal zone of the most immature preterm infants approached those of term infants at term equivalent. In contrast, the fetal zone in more mature preterm infants undergoes more rapid involution. These data in exclusively well neonates can serve as a basis to investigate the effects of illness on the FZS metabolome in future studies.